ORTX - Orchard Therapeutics: An Undervalued Stock With Upcoming Catalysts November, 04 2020 08:41 AM Orchard Therapeutics plc Orchard just received a positive node from CHMP for its lead drug candidate. US approval should be next. The stock's low price makes no sense. For further details see: Orchard Therapeutics: An Undervalued Stock With Upcoming Catalysts